|Bid||3.9500 x 900|
|Ask||4.2000 x 1100|
|Day's range||3.9400 - 4.0563|
|52-week range||3.9000 - 13.6400|
|Beta (5Y monthly)||0.92|
|PE ratio (TTM)||N/A|
|Earnings date||09 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||16.67|
STONY BROOK, N.Y., January 04, 2022--Applied DNA's ADCL receives conditional approval from NYSDOH for Linea 2.0 COVID-19 Assay; Intends to file near-term EUA for assay and at-home kit.
STONY BROOK, N.Y., December 15, 2021--The power of DNA used to confirm cotton authenticity and provenance is now augmented with stable isotope analysis.
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -53.13% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?